Health Law Alliance Welcomes Dr. Martha Rumore's Expertise as Of Counsel

Health Law Alliance Welcomes Dr. Martha Rumore

The Health Law Alliance has made a significant addition to its legal team by welcoming Dr. Martha M. Rumore as Of Counsel. A distinguished pharmacist-attorney and registered patent attorney, Dr. Rumore brings over 20 years of extensive experience in the fields of FDA regulations, DEA law, and pharmaceutical intellectual property. Her unique qualifications aim to enhance the firm's healthcare and regulatory practices, aligning perfectly with the Alliance's mission to defend pharmacies and healthcare organizations across the nation.

Dr. Rumore's impressive credentials include a Doctor of Pharmacy (Pharm.D.) from St. John’s University, a Juris Doctor (J.D.) from the CUNY School of Law, and a Master’s in Medical Communications and Drug Information from Long Island University. Furthermore, she holds a Master of Laws (LLM) in Intellectual Property from Benjamin N. Cardozo School of Law. She is admitted to practice in New York, New Jersey, and Washington D.C., and is a Fellow of the American Pharmacists Association, showcasing her dedication to advancing the pharmacy profession.

Before joining Health Law Alliance, Dr. Rumore played a crucial role as Senior Counsel at Frier Levitt in Manhattan. There, she specialized in regulatory compliance regarding FDA and DEA issues, Board of Pharmacy standards, and pharmaceutical intellectual property. Her expertise encompasses a diverse range of areas, including 503A and 503B compounding, Drug Supply Chain Security Act (DSCSA) compliance, recalls, clinical trial management, and various submission processes from 510(k) to Premarket Approval (PMA) applications. With this breadth of knowledge, she significantly contributes to the firm’s capability to navigate complex legal landscapes.

Dr. Rumore’s leadership experience in the pharmaceutical industry is notable as well. Previously serving as Associate Director of Medical Affairs at Glenbrook Laboratories/Sterling Drug, she has demonstrated a comprehensive understanding of both pharmaceutical operations and regulatory frameworks. Her academic contributions are also remarkable; she has taught courses on Drug Regulatory Affairs and Food, Drug, and Cosmetic Law at prestigious institutions such as Hofstra University’s Maurice A. Deane School of Law.

With a portfolio of over 200 publications and presentations, Dr. Rumore is recognized as a sought-after national lecturer on topics related to FDA regulations and pharmacy law. Her extensive knowledge and communication skills make her an invaluable resource for the Health Law Alliance and its clients.

Anthony Mahajan, the founder of Health Law Alliance, expressed enthusiasm about Dr. Rumore's addition, stating, “Martha is a powerhouse addition to our team. Her unique blend of pharmacy practice, legal expertise, and regulatory insight further strengthens our ability to defend pharmacies, providers, and healthcare organizations nationwide.”

In a landscape where healthcare laws and regulatory conditions continue to evolve, the inclusion of Dr. Rumore signifies Health Law Alliance's commitment to staying at the forefront of legal excellence. Her role as Of Counsel will undoubtedly enhance the firm's ability to address the complex challenges faced by its clients in the healthcare sector.

For more information or inquiries, interested parties can reach out to Health Law Alliance at (800) 345-4125 or via email at [email protected]

In conclusion, the Health Law Alliance is excited about this new chapter with Dr. Rumore. Her expertise illustrates a dedication to the highest standards of healthcare law, promising robust support for pharmacies and healthcare professionals in navigating the regulatory landscape effectively.